TERT p.Arg671Gln
c.2012G>A · rs774381540 · VCV579067
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0647 | likely benign |
|---|---|---|
| REVEL | 0.189 | benign-leaning |
| SaProt | LLR -6.32 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.2 | GERP -2.5 |
| Regional constraint | o/e 0.58 | unconstrained · MANE · 29 kb · p 2.3e-32 · regional, not allelic |
| Overall | ||
| CADD | 7.301 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.0244% | 4,098 |
| Remaining individualsnot grpmax-eligible | 0.00333% | 30,031 |
| East Asiangrpmax | 0.00243% | 41,186 |
| European (non-Finnish) | 0.002% | 49,968 |
| Admixed American | 0.00195% | 51,342 |
| African / African-American | 0.00136% | 73,302 |
| South Asian | 0.00119% | 84,224 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- TERT
- Protein
- p.Arg671Gln
- Coding
- c.2012G>A
- MANE Select
- NM_198253
- dbSNP
- rs774381540
- Type
- single nucleotide variant
- Location
- chr5:1279409 (GRCh38)
- Gene constraint
- LOEUF 0.593 · pLI <0.01 · ClinGen HI 1/3 (gnomAD)
- Structure
- AlphaFold pLDDT 80.98 · 32 PDB
- Residue 671
- the reverse transcriptase domain; an α-helix
Disease context
acute myeloid leukemia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: dyskeratosis congenita, autosomal dominant 2pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1melanoma, cutaneous malignant, susceptibility to, 9dyskeratosis congenitaidiopathic pulmonary fibrosis
Similar variants
- TERT p.Arg671Trp Pathogenic/Likely pathogenic ★★ ⚠ same residue
- TERT p.Arg671= Likely benign ★★ same residue
- TERT p.Arg671Gly Conflicting classifications of pathogenicity ★ ⚠ same residue
- TERT p.Arg671Pro Uncertain significance ★ ⚠ same residue
- TERT c.2130+1G>A Likely pathogenic ★★ same condition
- TERT c.2130+2T>G Likely pathogenic ★★ same condition
- TERT c.2131-2A>G Likely pathogenic ★★ same condition
- TERT c.2286+1G>A Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tert-p-arg671gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown